The document provides a comparative timeline analysis of five major Indian pharmaceutical companies - Sun Pharma, Cipla, Zydus Cadila, GSK, and Mankind Pharma. It outlines the founding year, headquarters, share price and employee numbers for each company. It then analyzes their annual revenues from 2005-2014 and percentage changes year-over-year. The rest of the document details key events and acquisitions in the history of each company and recent news announcements. It concludes by projecting India will become the third largest pharmaceutical market by 2020 and a top exporter of generics globally.

1. Analysis on
Comparative Time
line analysis of Indian
Pharmaceutical
Industry
Presented By:
Amar Shakti Kumar

2. Events & timeline analysis

3. Company Profile
Comp. Founde
d in
Headquarte
rs
Share
Price(NSE)
(16-09-15)
Employe
e
products
Sun P. 1983 Mumbai 886.80
(+20.20)
32,700 Pharmaceuticals, generic
drugs
Cipla 1935 Mumbai 658.05
(-0.85)
22,036 Pharmaceuticals and
diagnostics
Z. cadila 1952 Ahmedabad 1894.00
(+99.55)
11000 Generic drugs
gsk 2000 Brentford,
London,
United
Kingdom
1296.24
(+6.24)
96,575 Medicines and vaccins
Mankind 1995 Okhla Delhi,
India
Does not
Issue
10000+ Pharmaceuticals, Generic
drugs, OTC, FMCG,
Diagnostics

4. Events & timeline analysis
Rs. In million
Comp. 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Sun P. 11852.8 16368.2 16,652.7 23,656.4 27,697.5 18,461.3 31,075.7 40,155.6 24321.4 28287.9
Cipla 2254.52 2981.35 3561.99 4203.29 5234.29 5605.69 6331.09 6977.50 8202.42 9380.29
Z. cadila 1090.00 1276.60 1450.30 1681.80 1743.40 1885.60 2920.30 3150.80 5675.70 4042.10
gsk 1474.07 1541.93 1578.58 1676.36 1884.14 2125.20 2375.88 2630.30 2546.15 3287.57
Mankin
d
190 335 486 618 812 1043 1588 1909 2383 3000

5. Increase and decrease in revenue
In %
Comp. 2006 2007 2008 2009 2010 2011 2012 2013 2014
Sun P.
28 2 30 15 -33 41 23 -39 14
Cipla
24 16 15 20 7 11 9 15 13
Z. cadila
15 12 14 4 8 35 7 44 -28
gsk
4 2 6 11 11 11 10 -3 23
Mankin
d 43 31 21 24 22 34 17 20 21

6. 0.00
5,000.00
10,000.00
15,000.00
20,000.00
25,000.00
30,000.00
35,000.00
40,000.00
45,000.00
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Rs.Inmillion
year
Sun P. Cipla Z. cadila gsk Mankind

7. 1983 • Company set in Vapi, Gujarat
1988
• First few cardiology products launched
1989
• Gastrology products introduced, exports to neighboring
countries began
1994
• IPO in October, listed in major stock exchanges in India,
offering oversubscribed 55 times
1996
• 1st acquisition - an API manufacturing unit from knoll
pharma
Events & timeline of sun pharma

8. 1997
• International acquisition- Caraco pharma Labs, Mj
pharma
2004
• Acquired phlox pharma- Cephalosporin actives
manufacturer
2010
• Acquired Taro pharma, size of US business doubled
2014
• Acquired Ranbaxy labs for $3.2 m, sun becomes largest
company in India, 5th largest globally
Cont.

9. Events & timeline of Cipla
1935
• Company set in Mumbai as a Pharmaceutical
Laboratories
1984
• The name of the company was changed to Cipla ltd.
1985
• US FDA approved the company's bulk drug
manufacturing facilities
1994
• Cipla launched Deferiprone, the world's first oral iron
chelator.
2001
• Cipla offered medicines for HIV treatment at a fractional
cost ( less then $350 per year per patient)
2012
• The company slashed prices of three life-saving cancer
drugs by 50 to64%

10. Events & timeline of Mankind
1995
• Inception of mankind pharma
2000
• Company established its operation all over India
• Launched new division discovery for the segment-
diabetic, metabolic disorder, antibiotics, gastro intestinal,
anti-fungal.
2005
• Launched le fester pharma segment- antibacterial.
• Won the Indian express pharma pulse award for "overall
best performance".
2006
• Established inject able state of the art unit at paonta
sahib

11. Cont.
2007
• Launched future mankind, special mankind, vet
mankind
• Chrys capital became an investor partner
2007
cont.
• Teamed up with Roche diagnostic for the marketing of
product ‘Accuchek go'
2008
• Certified as the most potential& "A" grade vendor in
supply chain management by HINDALCO
2010
• Launched OTC products like prega news, unwanted-72,
don't worry
• Spread the wings globally with the launched of mankind
in Srilanka

12. Cont.
2010
• Established state of art manufacturing unit for liquid
dosages & tablets
2011
• Incorporation of the R&D centre- mankind research
centre in NCR
• Successfully acquired longifene- the former brand of
UCB Belgium
2011
cont.
• Launched a new division "pet Mankind" for the basic
care, health care, hygiene and nutritional need of pet's
2012
• They plan to add another 1000 people to their
workplace within two years .

13. Events & timeline of Z. Cadila healthcare
1952
• Cadila laboratories was founded
2000
• Issue IPO in BSE
2001
• Company required another Indian Pharmaceutical
company called German Remedies

14. Cont.
2007
• Comapny signed an agreement to acquire 100 %
stake in Brazil's Quimica e Farmaceutica Nikkho do
Brasil Ltda ( Nikkho) for around 26 million dollars.
2010
• Received a prestigious Welcome trust award under
the new R&D for affordable healthcare in India
2014
• Launched the world's first adalimumab biosimilar
under the brand name Exemptia (immune disorders)

15. Events & timeline of GSK
1924
• It was established in India under the name of H.J. Foster &
Co. ltd.
2000
• Glaxo wellcome and smithkline beecham announced
their intention to merge and become glaxosmithkline
2002
• The company global headquarters are at GSK house
Brenftord, london officially opened by prime minister
Tony Blair
2005
• Chris Gent , former CEO of Vodaphone, has been the
chair since 2005
2008
• Andrew Witty took over as CEO

16. Cont.
2012
• GSK pleaded guilty to criminal charges in the united
state and agreed to pay a $3 billion settlement ( the
charges related to GSK’s promotion of drugs for
unapproved uses) medicine was anti- depressants
2013
• The company announced that it would no longer
pay physicians to promote its drugs
2015
• Philip Hampton, chair of Royal Bank of Scotland, will
replace Gent in September 2015

17. Current News
Sun Pharma (16 September 2015)
 Agreement with US Eye Care firm for around 40 million
US $.
Cipla (17 July 2015)
 Announced to by Invagen Pharma inc. & Exelan Pharma
inc. about 550 Million USD in US

18. Cont…
Zydus Cadila (24 June 2015)
 Received final approval from US food and drug
administrations (USFDA) to sale Pyridostigmine
Bormide(PGB) Tablets.
GlaxoSmithKline (8 June 2015)
 CCI has imposed fine of Rs. 64 Crores for being indulge in
anti competitive activity. It had tried to fix entire bidding
for supply of maligning vaccines for HAZ Pilgrims.

19. Cont…
Mankind’s DHA Campaign (10 September 2015)
 MKD has arose the importance of DHA
among children.
 They reached 12000 Pediatricians and 20000
children to eliminate the DHA deficiency
from the Indian society in last 8 months.

20. FUTURE TREND
 3rd largest pharmaceuticals market by 2020.
 20% of global exports in generics.
 USD 45 Billion in revenue by 2020.
 USD 26.1 Billion in generics by 2016.
 USD 200 Billion to be spent on infrastructure by 2024.
 49% of all drug master filings registered in the USA.

21. How?
21

22. THANK YOU!